Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Telix Pharmaceuticals Limited (ASX:TLX): Operations, Recent Results and Business Developments

Telix Pharmaceuticals Limited (ASX:TLX) is involved in radiopharmaceutical medicines and precision diagnostics for cancer. Its portfolio combines commercially available prostate cancer imaging products with clinical-stage diagnostic and therapeutic candidates. The business also operates radiopharmacy and manufacturing capabilities serving nuclear medicine customers. During trading on …

Aditi Sarkar | 20 October 2026

Neuren Pharmaceuticals Limited (ASX:NEU): Operations, Recent Results and Business Developments

Neuren Pharmaceuticals Limited (ASX:NEU) is involved in treatments for neurological disorders associated with genetic abnormalities or brain injury. The company receives royalties through its licensed trofinetide therapy and develops NNZ-2591, also called ercanetide, for several neurodevelopmental conditions. Trofinetide is commercialised by licensee Acadia Pharmaceuticals. …

Aditi Sarkar | 20 October 2026

Mesoblast Limited (ASX:MSB): Operations, Recent Results and Business Developments

Mesoblast Limited (ASX:MSB) is involved in cellular medicines for inflammatory and immune-mediated conditions. Its work centres on allogeneic cell therapies, commercial manufacturing and late-stage studies targeting serious medical conditions. Research execution and regulated product supply are central parts of its operating model. During trading …

Aditi Sarkar | 20 October 2026

PYC Therapeutics Limited (ASX:PYC): Operations, Recent Results and Business Developments

PYC Therapeutics Limited (ASX:PYC) is involved in RNA-based medicines for inherited genetic diseases. Its programs use RNA therapies and peptide-based delivery technology to address genetically linked conditions affecting the eye, kidney and central nervous system. Its pipeline comprises clinical and development-stage programs. During trading …

Aditi Sarkar | 20 October 2026

Regis Healthcare Limited (ASX:REG): Operations, Recent Results and Business Developments

Regis Healthcare Limited (ASX:REG) is involved in residential aged care and related services across Australia. Regis operates aged-care homes and related support services, including respite and other care offerings. Its earnings profile depends on resident occupancy, government funding, service pricing and staff costs. During …

Aditi Sarkar | 20 October 2026

Nanosonics Limited (ASX:NAN) Advances CORIS Commercialisation Following FY26 Results

Nanosonics Limited develops medical-device reprocessing technologies used by healthcare providers, including the trophon ultrasound-probe disinfection platform and the CORIS flexible-endoscope cleaning system. Its latest financial results and preparations for CORIS commercialisation place product adoption and operating expenditure in focus. On 20 October 2026, Nanosonics …

Aditi Sarkar | 20 October 2026

Integral Diagnostics (ASX:IDX): Medical Imaging Network, Leadership Transition and Operating Priorities

Integral Diagnostics (ASX:IDX) operates through a collection of regional and metropolitan radiology practices rather than a single consumer-facing clinic brand. Its services include X-ray, computed tomography, magnetic resonance imaging, ultrasound, mammography, nuclear medicine and selected image-guided procedures. Referrals originate from doctors and other healthcare …

Aditi Sarkar | 20 October 2026

Clarity Pharmaceuticals (ASX:CU6): Prostate Cancer Trial Progress and Clinical Development

Clarity operates as a clinical-stage pharmaceutical developer rather than a commercial producer of approved medicines. Its Targeted Copper Theranostics approach pairs copper-64 imaging agents with copper-67 therapeutic agents, allowing a related targeting molecule to serve diagnostic and treatment functions. This work involves radiochemistry, clinical …

Aditi Sarkar | 20 October 2026

PolyNovo Limited (ASX:PNV): Wound Care Sales, Manufacturing and Regulatory Milestones

PolyNovo markets two complementary wound-management products: NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. BTM is a two-layer synthetic scaffold used in complex burns, trauma and surgical reconstruction; MTX is a synthetic dermal matrix without the temporary sealing membrane. Both use the company’s polymer …

Aditi Sarkar | 20 October 2026

Australian Clinical Labs (ASX:ACL): FY26 Earnings, Pathology Operations and Priorities

Australian Clinical Labs operates a national pathology network supporting general practitioners, specialists, hospitals and corporate clients. Services include haematology, chemical pathology, microbiology, histopathology, genetics, cardiac testing and occupational drug and alcohol screening. The company also provides tests used in fertility treatment and clinical trials. …

Aditi Sarkar | 20 October 2026
Support

Hi! How can we help you today?

Loading…